0001628280-24-000639.txt : 20240105
0001628280-24-000639.hdr.sgml : 20240105
20240105155200
ACCESSION NUMBER: 0001628280-24-000639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231017
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ACKERMAN JOEL
CENTRAL INDEX KEY: 0001220630
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11504
FILM NUMBER: 24516080
MAIL ADDRESS:
STREET 1: COVENTRY HEALTH CARE, INC.
STREET 2: 6705 ROCKLEDGE DR SUITE 900
CITY: BETHESDA
STATE: MD
ZIP: 20817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC.
CENTRAL INDEX KEY: 0000771856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521401755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 410-369-0365
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC.
DATE OF NAME CHANGE: 20070220
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS SPORTS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: INTERNATIONAL GROUP INC
DATE OF NAME CHANGE: 19860319
4
1
wk-form4_1704487909.xml
FORM 4
X0508
4
2023-10-17
0
0000771856
CHAMPIONS ONCOLOGY, INC.
CSBR
0001220630
ACKERMAN JOEL
C/O CHAMPIONS ONCOLOGY, INC.
ONE UNIVERSITY PLACE, SUITE 307
HACKENSACK
NJ
07601
1
0
0
0
0
Common Stock
2023-10-17
4
M
0
114552
2.10
A
856997
D
Option to purchase Common Stock
2.10
2023-10-17
4
M
0
100000
2.10
D
2016-07-19
2023-11-05
Common Stock
100000
0
D
Option to purchase Common Stock
2.10
2023-10-17
4
M
0
14552
2.10
D
2016-07-19
2023-11-05
Common Stock
14552
0
D
84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016.
The options were immediately exercisable upon grant on July 19, 2016.
/s/ Joel Ackerman
2024-01-05